Peter D Meldrum - Net Worth and Insider Trading

Peter D Meldrum Net Worth

The estimated net worth of Peter D Meldrum is at least $166,574 dollars as of 2024-05-13. Peter D Meldrum is the President & C.E.O. of Myriad Genetics Inc and owns about 6,540 shares of Myriad Genetics Inc (MYGN) stock worth over $166,574. Details can be seen in Peter D Meldrum's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Peter D Meldrum has not made any transactions after 2014-07-14 and currently still holds the listed stock(s).

Transaction Summary of Peter D Meldrum

To

Peter D Meldrum Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Peter D Meldrum owns 2 companies in total, including Endocyte Inc (ECYT) , and Myriad Genetics Inc (MYGN) .

Click here to see the complete history of Peter D Meldrum’s form 4 insider trades.

Insider Ownership Summary of Peter D Meldrum

Ticker Comapny Transaction Date Type of Owner
ECYT Endocyte Inc 2017-05-04 director
MYGN Myriad Genetics Inc 2014-07-14 director & President

Peter D Meldrum Latest Holdings Summary

Peter D Meldrum currently owns a total of 1 stock. Peter D Meldrum owns 6,540 shares of Myriad Genetics Inc (MYGN) as of July 14, 2014, with a value of $166,574.

Latest Holdings of Peter D Meldrum

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MYGN Myriad Genetics Inc 2014-07-14 6,540 25.47 166,574

Holding Weightings of Peter D Meldrum


Peter D Meldrum Form 4 Trading Tracker

According to the SEC Form 4 filings, Peter D Meldrum has made a total of 0 transactions in Myriad Genetics Inc (MYGN) over the past 5 years. The most-recent trade in Myriad Genetics Inc is the sale of 24,000 shares on July 14, 2014, which brought Peter D Meldrum around $948,000.

Insider Trading History of Peter D Meldrum

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Peter D Meldrum Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Peter D Meldrum Ownership Network

Ownership Network List of Peter D Meldrum

No Data

Ownership Network Relation of Peter D Meldrum


Peter D Meldrum Owned Company Details

What does Endocyte Inc do?

Who are the key executives at Endocyte Inc?

Peter D Meldrum is the director of Endocyte Inc. Other key executives at Endocyte Inc include VP Finance & Chief Acctg Off Beth Taylor , General Counsel David R. Mcavoy , and Chief Medical Officer Alison A. Armour .

Endocyte Inc (ECYT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Endocyte Inc (ECYT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Endocyte Inc (ECYT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Endocyte Inc (ECYT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Endocyte Inc Insider Transactions

No Available Data

Peter D Meldrum Mailing Address

Above is the net worth, insider trading, and ownership report for Peter D Meldrum. You might contact Peter D Meldrum via mailing address: 320 Wakara Way, Salt Lake City Ut 84108.

Discussions on Peter D Meldrum

No discussions yet.